Overview

The Quick Inventory of Depressive Symptomatology (QIDS) is a brief instrument designed to quantify the severity of depressive symptoms in a way that maps onto the symptom domains that define a major depressive episode. The most widely used self-report form, QIDS-SR16, contains sixteen items. Each item is rated on a four-point scale from absent or minimal burden to severe symptom intensity, with standard administration referring to the past seven days. The instrument is used in clinical trials, outpatient psychiatry, primary care, and research settings where repeated measurement of depression severity is needed alongside other outcomes.

QIDS belongs to the same measurement family as the longer Inventory of Depressive Symptomatology (IDS). Where the IDS provides broad coverage of depressive signs and symptoms, QIDS distills that content into a smaller set of items that still sample the core domains required for a coherent severity score. Because the total score is constructed from nine symptom domains rather than a simple sum of sixteen lines, understanding the scoring rules is essential; miscalculation most often occurs when raters add every item instead of applying the domain maxima described below.

Forms: self-report and clinician-rated

QIDS is available as a self-report (QIDS-SR) version and a clinician-rated (QIDS-C) version. The item content and the scoring algorithm for the sixteen-item forms are aligned so that, when properly administered, the two formats target the same constructs. Self-report administration assumes adequate reading ability and capacity to reflect on symptoms over the designated recall period. When literacy, cognitive impairment, acute agitation, or language barriers interfere with reliable self-report, a structured clinician interview may be preferable. In all cases, the score reflects reported symptom burden during the reference window and must be integrated with history, examination, context, and safety assessment.

Time frame and response scale

Standard instructions ask respondents to consider symptoms over the last seven days. This differs from some other common depression screens that use a two-week window, so clinicians should be explicit about which instrument and which timeframe were used when comparing scores over time or across visits. Each QIDS item is typically scored from 0 to 3, with higher values indicating greater severity or greater frequency-intensity of the symptom, depending on the item anchors on the official form. Because item anchors are written for each symptom, clinical-grade use should follow the published item text rather than paraphrasing response options.

Structure of the sixteen items

The sixteen items sample nine domains that correspond to major depressive episode criteria as operationalized in the QIDS framework. Some domains are represented by multiple items that capture different facets of the same underlying problem—such as several types of sleep disturbance or several manifestations of appetite and weight change. Other domains are represented by a single item. This design acknowledges that patients may experience insomnia in different ways, or may have either decreased or increased appetite, without forcing a single item to capture mutually exclusive presentations.

Domain-based scoring (how the 0–27 total is built)

The total QIDS score ranges from 0 to 27. It is not the sum of all sixteen item scores. Instead, the total is the sum of nine domain scores, where each domain contributes a single value between 0 and 3, except that some domains are computed as the maximum of two or more items within a cluster.

The standard published rule set can be summarized as follows:

• Sleep disturbance (items 1–4): Enter the highest score among the four sleep-related items. Only one sleep value contributes to the total, even if multiple sleep symptoms are endorsed.
• Depressed mood (item 5): This domain is represented by a single item; its score enters the total directly.
• Appetite and weight disturbance (items 6–9): Enter the highest score among the four items that capture decreased or increased appetite and decreased or increased weight. As with sleep, only one value from this cluster contributes.
• Decreased interest or pleasure (item 10): Single item; enters directly.
• Items 11–14: Each of these items represents its own domain and each score enters the total separately. On the official instrument these typically correspond to constructs such as concentration or decision-making, energy or fatigue, self-critical or guilty cognitions, and suicidal ideation or related thoughts. Always use the official item labels and anchors when interpreting what each numeric level means clinically.
• Psychomotor disturbance (items 15–16): Enter the higher of the two psychomotor items (for example, features of slowing versus agitation or restlessness). Only one psychomotor value contributes.

In formula form, the computation is:

Total = max(items 1–4) + item 5 + max(items 6–9) + item 10 + item 11 + item 12 + item 13 + item 14 + max(items 15–16)

When scores are hand-calculated, a common error is to sum all sixteen lines. Automated calculators, including the one on this site, apply the maxima so the total remains within the intended 0–27 range and reflects the nine-domain architecture.

Interpreting the total score

After correct scoring, the total is commonly interpreted using severity bands that are widely cited in the literature and in scoring documentation. A typical mapping is:

• 0–5: No depression or minimal symptom burden on this measure
• 6–10: Mild depression severity
• 11–15: Moderate depression severity
• 16–20: Severe depression severity
• 21–27: Very severe depression severity

These bands describe symptom severity on the instrument. They are not, by themselves, equivalent to a formal diagnosis of major depressive disorder, which requires a clinical assessment that considers duration, functional impairment, exclusion of other conditions, and diagnostic criteria in the appropriate edition of diagnostic manuals. Likewise, a lower score does not guarantee absence of risk; safety concerns can occur across the full range of totals and require independent evaluation.

Clinical and research applications

QIDS is frequently used to track change during treatment, including medication trials and psychotherapy studies, because it is short enough for repeated administration yet sensitive to the symptom domains most central to depression. In clinical practice, serial QIDS scores can complement structured interviews and global clinical impression measures. When using QIDS longitudinally, consistency matters: keep the form version, timeframe, and language stable where possible, and interpret apparent changes alongside sleep medication changes, substance use, medical illness flares, and psychosocial stressors that can move scores independent of core mood changes.

QIDS can also be used alongside other measures. For example, some settings pair depression severity scales with anxiety measures, functional scales, or disorder-specific tools. Any multi-instrument panel should be interpreted holistically, avoiding over-weighting a single number.

Safety and suicidal ideation

QIDS includes content that can identify suicidal thoughts. A nonzero score on the suicidal ideation item, or any disclosure of self-harm intent during review, should trigger a structured safety assessment appropriate to the setting, including evaluation of intent, plan, means, impulsivity, protective factors, and need for urgent or emergent services. Automated calculators and educational articles cannot replace direct clinical risk assessment.

Strengths and limitations

Strengths include brevity, alignment with depressive symptom domains, a total score with established severity bands, and compatibility with both research and clinical workflows. The domain-based scoring reduces double-counting when multiple items capture different manifestations of the same domain (notably sleep, appetite/weight, and psychomotor change).

Limitations include dependence on accurate recall over seven days, potential cultural and linguistic variation in item interpretation, and the fact that severity scales do not capture all clinically relevant features such as psychotic symptoms, manic polarity, substance-induced states, or medical mimics of depression unless those issues are assessed separately. Scores can be influenced by sleep disorders, chronic pain, thyroid disease, anemia, stimulant or sedative use, and situational stress. Finally, cut points are probabilistic descriptors of severity on a scale; they should not be treated as rigid treatment thresholds without individualization.

Practical tips for accurate use

• Confirm you are using the correct QIDS form (sixteen-item QIDS versus longer IDS forms).
• Apply the seven-day timeframe consistently across visits when monitoring change.
• Compute the total using domain rules (maxima for items 1–4, 6–9, and 15–16).
• Integrate the score with function, safety, comorbidity, and patient preferences when making treatment decisions.